Lopinavir/Ritonavir (LPV/r) (40mg/10mg Per Capsule) Oral Pellets - Job Aid and Fact Sheet

Lopinavir/Ritonavir (LPV/r) (40mg/10mg Per Capsule) Oral Pellets - Job Aid and Fact Sheet

LPV/r oral pellets are a better tasting alternative to LPV/r syrup for the treatment of HIV in children who cannot tolerate the LPV/r syrup. The pellets are used in combination with other ARVs: They have an improved taste, are easy to swallow and don’t need to be stored in the fridge (they can be stored at room temperature). As this is a new product, healthcare workers must demonstrate how to administer oral pellets to caregivers (instructions are given below). Eligibility: Children have to be eligible to take LPV/r oral pellets Children are only eligible if they meet all the following criteria: are older than 6 months, can swallow foods, cannot tolerate the LPV/r syrup and cannot swallow whole LPV/r tablets. Children who don’t fulfil the above criteria can take the LPV/r syrup or the LPV/r tablets.

Type
Tools and Templates
Topic
HIV/AIDS
HIV/AIDS, HIV/AIDS, TB, Maternal and Child Health
Language
English
Publisher
National Department of Health
Year
2021